Flora Growth (FRA:7301) ROCE % : -153.98% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Flora Growth ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Flora Growth's annualized ROCE % for the quarter that ended in Sep. 2024 was -153.98%.

Flora Growth ROCE % Historical Data

The historical data trend for Flora Growth's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth ROCE % Chart

Flora Growth Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-183.98

-45.17

-29.72

-132.51

Flora Growth Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial													17.34	-263.59	-210.08	-154.43	-153.98

Flora Growth ROCE % Calculation

Flora Growth's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-44.204	/	( ( (76.452 - 16.47)	+	(21.665 - 14.929) )	/ 2 )
	=	-44.204	/	( (59.982	+	6.736)	/ 2 )
	=	-44.204	/	33.359
	=	-132.51 %

Flora Growth's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-14.188	/	( ( (27.947 - 17.079)	+	(26.385 - 18.825) )	/ 2 )
	=	-14.188	/	( ( 10.868	+	7.56 )	/ 2 )
	=	-14.188	/	9.214
	=	-153.98 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Flora Growth (FRA:7301) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Flora Growth ROCE % Related Terms

Thank you for viewing the detailed overview of Flora Growth's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Flora Growth Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (FRA:7301) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

FLGC:USA 7301:Germany

Address

3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132

Website

https://www.floragrowth.com

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Flora Growth Headlines

No Headlines